Related Experiment Video
Updated: Jul 16, 2026
06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Nutritional Alterations in Drug Abusers With and Without HIV
1Department of Public Health and Family Medicine, Tufts University School of Medicine 136 Harrison Ave, Boston MA 02111.
American Journal of Infectious Diseases
|March 16, 2007
Summary
Drug abusers often show nutritional deficits, but studies lack evidence of insufficient dietary intake. This review explores other potential causes for these nutritional issues in drug users.
Area of Science:
- Nutritional Science
- Addiction Research
- Public Health
Background:
- Drug abuse is frequently associated with nutritional deficits, such as weight loss.
- Dietary insufficiency is often cited as the primary cause of these deficits.
- However, objective dietary intake assessments have not consistently supported this explanation.
Purpose of the Study:
- To review the literature on the nutritional status of drug abusers.
- To investigate the nutritional status of drug abusers with and without HIV.
- To focus on dietary energy and macronutrient intake in this population.
Main Methods:
- Literature review of published studies.
- Analysis of nutritional status in drug abusers.
- Examination of dietary energy and macronutrient intake data.
Main Results:
- Objective measures of dietary intake have not confirmed widespread dietary insufficiency among drug abusers.
- Alternative mechanisms contributing to nutritional deficits require further investigation.
- Nutritional status varies between drug abusers with and without HIV.
Conclusions:
- The link between drug abuse and nutritional deficits may not solely be due to insufficient food intake.
- Further research is needed to explore other factors influencing nutrient status in drug abusers.
- Understanding these factors is crucial for developing effective interventions.
More Related Videos
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...